Shire PLC (SHP.L)
12 Dec 2017
* SHIRE PLC SAYS NEW FORMULATION OF ONCASPAR RECEIVES MARKETING AUTHORIZATION IN EUROPE FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
* SHIRE PLC SAYS JOHN MILLER TO SERVE AS INTERIM CFO WITH EFFECT FROM JAN 1, 2018 UNTIL THOMAS DITTRICH COMMENCES HIS EMPLOYMENT WITH CO - SEC FILING
Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
Dec 5 Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
BRIEF-Shire And Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill technology
* SHIRE AND RANI THERAPEUTICS ENTER INTO COLLABORATION TO EVALUATE USE OF THE RANI PILL(TM) TECHNOLOGY FOR THE ORAL DELIVERY OF FACTOR THERAPY
* Shares in rival Shire climb 6 pct (Adds projected price of drug, company comment)
* Omega Advisors Inc dissolves share stake in Carrizo Oil & Gas Inc - SEC Filing
* Third Point LLC dissolves Class A share stake in Charter Communications Inc - SEC filing
* Xenetic Biosciences enters into sublicense agreement related to its Polyxen technology with Baxalta Inc., a wholly-owned subsidiary of Shire Plc
LONDON Shire will start making a genetic disease medicine itself after it was hit by supply problems, the London-listed firm said on Friday as it reported a sharp rise in profit.
- Now is the perfect time to buy these 3 healthcare stocks!
- 2 'must-have' healthcare stocks after today's updates?
- Simply the best growth stocks in the FTSE 100?
- Are these 3 Brexit beaters set to fly after today's news?
- Are these 3 stocks due for a serious price correction?
- Should you buy Shire plc, Marks and Spencer Group plc and Amec Foster Wheeler plc following today's news?